Literature DB >> 12030376

Early changes in myocardial antioxidant enzymes in rats treated with adriamycin.

Timao Li1, Igor Danelisen, Pawan K Singal.   

Abstract

Increased oxidative stress and antioxidant deficit have been suggested to play a major role in adriamycin-induced cardiomyopathy and congestive heart failure due to multiple treatments with adriamycin (doxorubicin). In this study, we investigated the acute effects of a single dose of adriamycin on myocardial antioxidant enzymes in rats. Adriamycin (2.5 mg/kg) was injected (i.p.) and myocardial antioxidant enzyme activities, mRNA abundance and protein levels at 1, 2, 4 and 24 h were examined. While manganese superoxide dismutase (MnSOD), glutathione peroxidase (GSHPx) and catalase (CAT) activities were not significantly changed, copper-zinc superoxide dismutase (CuZnSOD) activity was reduced at all time points and this change correlated with a decrease in its protein content. CuZnSOD mRNA was increased at 1 and 24 h. GSHPx mRNA and protein levels were transiently decreased by 20 and 25% respectively at 2 h. MnSOD mRNA was not significantly changed, but its protein levels were significantly decreased at 1 h. Lipid peroxidation was increased transiently at 1, 2 and 4 h. A transient depression in antioxidant enzyme as well as transient increase in oxidative stress with a single dose of adriamycin may precede more sustained changes seen with the repeated administration of the drug and contribute to the development of cardiomyopathy and heart failure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12030376     DOI: 10.1023/a:1014862912783

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  41 in total

Review 1.  Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review).

Authors:  R Schreck; K Albermann; P A Baeuerle
Journal:  Free Radic Res Commun       Date:  1992

2.  Molecular basis for tumor necrosis factor-induced increase in pulmonary superoxide dismutase activities.

Authors:  M F Tsan; J E White; C Treanor; J B Shaffer
Journal:  Am J Physiol       Date:  1990-12

Review 3.  The anthracycline antineoplastic drugs.

Authors:  R C Young; R F Ozols; C E Myers
Journal:  N Engl J Med       Date:  1981-07-16       Impact factor: 91.245

4.  The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice.

Authors:  H C Yen; T D Oberley; S Vichitbandha; Y S Ho; D K St Clair
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

5.  Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol.

Authors:  T Li; P K Singal
Journal:  Circulation       Date:  2000-10-24       Impact factor: 29.690

6.  Multiple mRNA species generated by alternate polyadenylation from the rat manganese superoxide dismutase gene.

Authors:  J Hurt; J L Hsu; W C Dougall; G A Visner; I M Burr; H S Nick
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

7.  Endotoxin increases lung Cu,Zn superoxide dismutase mRNA: O2 raises enzyme synthesis.

Authors:  J Iqbal; L B Clerch; M A Hass; L Frank; D Massaro
Journal:  Am J Physiol       Date:  1989-08

8.  Hyperoxia, unlike phorbol ester, induces glutathione peroxidase through a protein kinase C-independent mechanism.

Authors:  L Jornot; A F Junod
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

9.  Effect of anthracycline antibiotics on oxygen radical formation in rat heart.

Authors:  J H Doroshow
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

10.  Adriamycin stimulates low-affinity Ca2+ binding and lipid peroxidation but depresses myocardial function.

Authors:  P K Singal; G N Pierce
Journal:  Am J Physiol       Date:  1986-03
View more
  20 in total

1.  The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle.

Authors:  Laura A A Gilliam; Kelsey H Fisher-Wellman; Chien-Te Lin; Jill M Maples; Brook L Cathey; P Darrell Neufer
Journal:  Free Radic Biol Med       Date:  2013-09-07       Impact factor: 7.376

2.  Targeted overexpression of mitochondrial catalase protects against cancer chemotherapy-induced skeletal muscle dysfunction.

Authors:  Laura A A Gilliam; Daniel S Lark; Lauren R Reese; Maria J Torres; Terence E Ryan; Chien-Te Lin; Brook L Cathey; P Darrell Neufer
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-06-21       Impact factor: 4.310

Review 3.  Systems biology approaches to adverse drug effects: the example of cardio-oncology.

Authors:  Sherry-Ann Brown; Nicole Sandhu; Joerg Herrmann
Journal:  Nat Rev Clin Oncol       Date:  2015-10-13       Impact factor: 66.675

Review 4.  Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress.

Authors:  Laura A A Gilliam; Daret K St Clair
Journal:  Antioxid Redox Signal       Date:  2011-06-15       Impact factor: 8.401

5.  Effects of fructose-1,6-diphosphate on concentration of calcium and activities of sarcoplosnic Ca2+-ATPase in cardiomyocytes of Adriamycin-treated rats.

Authors:  Wei Cai; Jun-zhu Chen; Li-ming Ruan; Yi-na Wang
Journal:  J Zhejiang Univ Sci B       Date:  2005-07       Impact factor: 3.066

6.  Uncoupling protein downregulation in doxorubicin-induced heart failure improves mitochondrial coupling but increases reactive oxygen species generation.

Authors:  Heiko Bugger; Cinthia Guzman; Christoph Zechner; Monica Palmeri; Kerry S Russell; Raymond R Russell
Journal:  Cancer Chemother Pharmacol       Date:  2010-08-31       Impact factor: 3.333

7.  Altered calsequestrin glycan processing is common to diverse models of canine heart failure.

Authors:  Sony Jacob; Naama H Sleiman; Stephanie Kern; Larry R Jones; Javier A Sala-Mercado; Timothy P McFarland; Hani H Sabbah; Steven E Cala
Journal:  Mol Cell Biochem       Date:  2013-03-01       Impact factor: 3.396

8.  Mitochondrials complex I activity is reduced in latent adriamycin-induced cardiomyopathy of rat.

Authors:  Kiyotaka Ohkura; Jong-Dae Lee; Hiromasa Shimizu; Akira Nakano; Hiroyasu Uzui; Motosaburo Horikoshi; Yasuhisa Fujibayashi; Yoshiharu Yonekura; Takanori Ueda
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

9.  Protective effect of tetrahydroxystilbene glucoside on cardiotoxicity induced by doxorubicin in vitro and in vivo.

Authors:  Shao-hui Zhang; Wen-quan Wang; Jia-ling Wang
Journal:  Acta Pharmacol Sin       Date:  2009-11       Impact factor: 6.150

10.  Anthracycline-based combined chemotherapy in the mouse model.

Authors:  M Popovic; J Kolarovic; M Mikov; S Trivic; B Kaurinovic
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Apr-Jun       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.